reference/32526396

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/32526396

Outgoing Links

Predicate	Object
contentType	Clinical Trial, Phase I\|Journal Article\|Research Support, N.I.H., Extramural\|Research Support, Non-U.S. Gov't
endingPage	4768
issn	1527-7755 0732-183X
issueIdentifier	31
pageRange	4762-4768
publicationName	Journal of clinical oncology : official journal of the American Society of Clinical Oncology
startingPage	4762
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_f747451f762898f6e8961757a6559e07 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_6eede3c4c2be1231845ab7bd136b1bfd http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_be6c102f66e104573d8232daee207e57
bibliographicCitation	Broniscer A, Baker JN, Tagen M, Onar-Thomas A, Gilbertson RJ, Davidoff AM, Pai Panandiker AS, Panandiker AP, Leung W, Chin TK, Stewart CF, Kocak M, Rowland C, Merchant TE, Kaste SC, Gajjar A. Phase I study of vandetanib during and after radiotherapy in children with diffuse intrinsic pontine glioma. J Clin Oncol. 2010 Nov 01;28(31):4762–8. PMID: 20921456; PMCID: PMC3020706.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_10d31ad4c1ff283b8a85ab58db9b239e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4f514bb40b583e2dc4d935f3fc08a164 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_daf965c155c7fa51aaf8b02ba36bd8c1 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-3386-1734 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_31845b4a6f4ddcde57fb361fb8ddd7fc http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d52529989c66eb72538eb3adb0b6c41e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_888392d3430f7fc421adbf1e0361942a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_16f9f14fd9696b880e2cdaee603440f9 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b8e7f3f456ac6ea37a7dcab8bee1475d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_17bda8c21c1b3e0795c12c74d76a2f4a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9b9477fba1e5e3c6f8e2739e0983a2c7 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_80970b3e8cb5384aa8e00bc17ffd1977 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-9646-0463 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b4d855a7f0c61b07b4ee2622a22813ec http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7cdd169e32311a8ca3d709e4ba713c75 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cd928b3cd83c915ecac10fcd3b2137e6 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2589427b55dc46a23b4f6bb046e435cf http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8e6db7666ac141da5cb8b837bf55bb61
date	2010-11-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/20921456 https://pubmed.ncbi.nlm.nih.gov/PMC3020706 https://doi.org/10.1200/jco.2010.30.3545
isPartOf	https://portal.issn.org/resource/ISSN/1527-7755 https://portal.issn.org/resource/ISSN/0732-183X http://rdf.ncbi.nlm.nih.gov/pubchem/journal/5023
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Phase I Study of Vandetanib During and After Radiotherapy in Children With Diffuse Intrinsic Pontine Glioma
discusses	http://id.nlm.nih.gov/mesh/M0421253 http://id.nlm.nih.gov/mesh/M0018336 http://id.nlm.nih.gov/mesh/M0016885 http://id.nlm.nih.gov/mesh/M0001483
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D000970Q000493 http://id.nlm.nih.gov/mesh/D000970Q000008 http://id.nlm.nih.gov/mesh/D005910Q000188 http://id.nlm.nih.gov/mesh/D020295Q000532 http://id.nlm.nih.gov/mesh/D005910Q000532 http://id.nlm.nih.gov/mesh/D011799Q000493 http://id.nlm.nih.gov/mesh/D010880Q000008 http://id.nlm.nih.gov/mesh/D020295Q000188 http://id.nlm.nih.gov/mesh/D010880Q000493 http://id.nlm.nih.gov/mesh/D011799Q000008
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D000970Q000009 http://id.nlm.nih.gov/mesh/D018572 http://id.nlm.nih.gov/mesh/D010880Q000009 http://id.nlm.nih.gov/mesh/D005910Q000175 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D018714 http://id.nlm.nih.gov/mesh/D008279 http://id.nlm.nih.gov/mesh/D016896 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D000293 http://id.nlm.nih.gov/mesh/D004334 http://id.nlm.nih.gov/mesh/D053208 http://id.nlm.nih.gov/mesh/D002675 http://id.nlm.nih.gov/mesh/D020714 http://id.nlm.nih.gov/mesh/D020295Q000175 http://id.nlm.nih.gov/mesh/D019583 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D055815 http://id.nlm.nih.gov/mesh/D017024 http://id.nlm.nih.gov/mesh/D011799Q000009 http://id.nlm.nih.gov/mesh/D002648
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_4fb3b68e84149f91bcfd0102f95d3731 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_8a41ddcd329749af8218828b17253c34 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_cb58e6788fc9a69c674bb00f98bffc14 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_fddb60309b0ee16f8cd57b4b90c99e89 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6701 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5743 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3081361 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID108157 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_714b3f52d8149c3277181d9513b93112 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11013 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7453 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8102

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID247533733

Total number of triples: 91.